Comments
Drug firm, Cadila Healthcare, on Tuesday, announced that Zydus Pharmaceuticals Inc, is included in the lawsuit filed against some generic companies by a few states of the US.
Zydus Pharmaceuticals Inc is the US arm of Cadila Healthcare.
According to some media reports, more than 40 states of the US have filed a lawsuit against Teva Pharmaceuticals and 19 other generic companies, for price fixing and inflating prices of drugs.
In a regulatory filing, Cadila said that in its opinion this particular matter is not likely to have any material impact on the operations and financials of the company.
“Zydus conducts its business with the highest degree of integrity and honesty,” it added.
Shares of Cadila Healthcare were trading at ₹265.10 per script on BSE and is down 1.41 per cent from its previous close.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.